Enhanced expression of Fas Ligand (FasL) in the lower airways of patients with fibrotic interstitial lung diseases (ILDs)
P Kopiński, B Balicka-Ślusarczyk… - Folia Histochemica …, 2011 - journals.viamedica.pl
The exact role of FasL, and particularly its soluble and membrane-bound forms, in the
development of chronic ILDs and lung fibrosis has not been extensively explored. We aimed …
development of chronic ILDs and lung fibrosis has not been extensively explored. We aimed …